干细胞表达的恶性基因模式有助于状细胞癌在不同部位的进展
Kaiyan Qi1, Guangqi Li2, Yuanjun Jiang3
1Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China.
Frontiers in genetics
|July 29, 2024
概括
研究人员在状细胞癌 (SCC) 中确定了两种恶性 stromal 基因模式 (V1 和 V5). 模式V5与患者存活时间缩短有关,而V1与手术后的不良结果相关,这表明SCCs的新分类系统.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 状细胞癌 (SCC) 在各种部位上具有共同的分子特征.
- 流体细胞在SCC进展和转移中发挥作用.
- 由于技术的局限性,将肌层表达与临床数据相结合是具有挑战性的.
研究的目的:
- 识别和验证SCC stromal细胞中的恶性基因模式.
- 为了研究这些 stromal 基因模式的预后价值.
- 建议对SCC进行改进的分类系统.
主要方法:
- 利用跨细胞系,单细胞和批量瘤测序数据的转移学习.
- 在头部和部 (HNSCC),肺部 (LUSC) 和宫 (CESC) SCC中确定并验证了两种结构基因模式 (V1和V5).
- 分析了基因模式与患者存活率和临床因素的关联.
主要成果:
- 模式V5,一种新的恶性特征,以HNSCC特有的方式与较短的无患者间隔 (PFI) 相相关.
- 模式V1与HNSCC,LUSC和CESC手术后的PFI差相关.
- 与癌症相关的纤维细胞可以诱导HNSCC细胞表达V1模式;放射治疗可以减轻V1的影响.
结论:
- 流体基因模式 (V1和V5) 具有预后价值,并且在SCC类型中保存.
- 建议采用SCC的综合分类系统,包括恶性和脑膜组分.
- 这种方法可以提高对SCC的理解和治疗.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K


